Adrenocorticotropic hormone (ACTH) is the major regulator of adrenocortical steroidogenesis in mammals. By comparing the sensitivity to ACTH of isolated adrenocortical cells from two sources of the same strain (Sprague-Dawley, SD) of outbred rats, we have identified a source of rat with low sensitivity to ACTH in vitro. Cells isolated from Holtzman SD rats had a high sensitivity to ACTH (minimal effective concentration 50 pg/ml), whereas Taconic SD rats had a low sensitivity (minimal effective concentration 250 pg/ml; maximal steroidogenesis <50% of Holtzman cells). The responsiveness to analogues of cyclic adenosine monophosphate and cholesterol was also significantly lower in Taconic SD rats. Taconic adrenals were smaller, had significantly more mitochondria per cell, but approximately 20% less total lipid droplet volume per cell. There was no difference in latency to ACTH in vitro; however, steroidogenesis plateaued in Taconic cells after 25 min, while Holtzman cells secreted corticosterone almost linearly for at least 120 min. By contrast, the cyclic adenosine monophosphate secretion increased at the same rate for at least 120 min in cells from both sources. There were no differences between cells from the two sources in immunoreactive steroidogenic enzyme content. In vivo, the magnitude of the ACTH and corticosterone responses to two types of stress were similar in both sources. The thymus glands of Holtzman rats were significantly larger than those of Taconic rats. It is concluded that: (1) reduced sensitivity to ACTH in vitro in Taconic SD rats results from differences in the later stages of the steroidogenic pathway; (2)  factors in addition to ACTH are required for maximal steroidogenesis in Taconic SD rats; (3) a comparison of the steroidogenic pathways in adrenal cells from these two sources of outbred rats should be useful in further delineating the relative importance of putative intracellular signalling mechanisms involved in initiation and maintenance of steroidogenesis, and (4) these data suggest that different sources of the same strain of rats sufficiently diverge over time to become separate strains (‘substrains’). Overreliance on a single source of laboratory rodent may obscure natural variability in endocrine responses to stress and provide a misleading indication of homogeneity of responses.

Keywords:
Corticotropin, Stress, cAMP, Adrenal steroids, Thymus
1.
Hornsby PJ: The mechanism of action of ACTH in the adrenal cortex; in Cooke BA, King RJB, van der Molen HJ (eds): Hormones and Their Actions. Amsterdam, Elsevier, 1988, pp 193–210.
2.
Papadopoulos V: Peripheral-type benzodiazepine/diazepam binding inhibitor receptor: Biological role in steroidogenic cell function. Endocr Rev 1993;14:222–240.
3.
Stocco DM: The steroidogenic acute regulatory (StAR) protein two years later. Endocrine 1997;6:99–109.
4.
Widmaier EP, Hall PF: Protein kinase C in adrenal cells: Possible role in regulation of steroid synthesis. Mol Cell Endocrinol 1985;43:181–188.
5.
Papadopoulos V, Widmaier EP, Hall PF: The role of calmodulin in the responses to adrenocorticotropin of plasma membranes from adrenal cells. Endocrinology 1990;126:2465–2473.
6.
Hall PF, Charponnier C, Nakamura M, Gabbiani G: The role of microfilaments in the response of adrenal tumor cells to adrenocorticotropic hormone. J Biol Chem 1979;254:9080–9089.
7.
Arai M, Widmaier EP: Steroidogenesis in isolated adrenocortical cells during development in rats. Mol Cell Endocrinol 1993;92:91–97.
8.
Engeland WC, Miller P, Gann DS: Dissociation between changes in plasma bioactive and immunoreactive adrenocorticotropin after hemorrhage in awake dogs. Endocrinology 1989;124:2978–2985.
9.
Sarel I, Widmaier EP: Stimulation of steroidogenesis in cultured rat adrenocortical cells by unsaturated fatty acids. Am J Physiol 1995;268:R1484–R1490.
10.
Widmaier EP, Iida S, Hall PF: The effect of polymyxin B on steroidogenesis from adrenocortical cells. Endocrinology 1987;121:290–297.
11.
Nagaya M, Arai M, Widmaier EP: Ontogeny of immunoreactive and bioactive microsomal steroidogenic enzymes during adrenocortical development in rats. Mol Cell Endocrinol 1995;114:27–34.
12.
Arai M, Widmaier EP: Activation of the pituitary-adrenocortical axis in day-old rats by insulin-induced hypoglycemia. Endocrinology 1991;129:1505–1512.
13.
Gauza C, Zubiaur M, Borrell J: Corticosteroidogenesis modulation by β-endorphin and dynorphin 1–17 in isolated rat adrenocortical cells. Peptides 1986;7:237–240.
14.
Hinson JP: Paracrine control of adrenocortical function: A new role for the medulla? J Endocrinol 1990;124:7–9.
15.
Jasper MS, Engeland WC: Splanchnic neural activity modulates ultradian and circadian rhythms in adrenocortical secretion in awake rats. Neuroendocrinology 1994;59:97–109.
16.
Kurtz TW, Montano M, Chan L, Kabra P: Molecular evidence of genetic heterogeneity in Wistar-Kyoto rats: Implications for research with the spontaneously hypertensive rat. Hypertension 1989;13:188–192.
17.
Dhabhar FS, McEwen BS, Spencer RL: Adaptation to prolonged or repeated stress: Comparison between rat strains showing intrinsic differences in reactivity to acute stress. Neuroendocrinology 1997;65:360–368.
18.
Gomez F, Lahmame A, de Kloet ER, Armario A: Hypothalamic-pituitary-adrenal response to chronic stress in five inbred rat strains: Differential responses are mainly located at the adrenocortical level. Neuroendocrinology 1996;63:327–337.
19.
Oitzl MS, van Haarst AD, Sutanto W, de Kloet ER: Corticosterone, brain mineralocorticoid receptors (Mrs) and the activity of the hypothalamic-pituitary-adrenal (HPA) axis: The Lewis rat as an example of increased central MR capacity and a hyporesponsive HPA axis. Psychoneuroendocrinology 1995;20:655–675.
20.
Sternberg EM, Scott Young W III, Bernardini R, Calogero AE, Chrousos GP, Gold PW, Wilder FL: A central nervous system defect in biosynthesis of corticotropin-releasing hormone is associated with susceptibility to streptococcal wall-induced arthritis in Lewis rats. Proc Natl Acad Sci USA 1989;86:4771–4775.
21.
Meaney MJ, Diorio J, Francis D, Widdowson J, La Plante P, Caldji C, Sharma S, Seckl JR, Plotsky PM: Early environmental regulation of forebrain glucocorticoid receptor gene expression: Implications for adrenocortical responses to stress. Dev Neurosci 1996;18:49–72.
22.
Liu D, Diorio J, Tannenbaum B, Caldji C, Francis D, Freedman A, Sharma S, Pearson D, Plotsky PM, Meaney MJ: Maternal care, hippocampal glucocorticoid receptors, and hypothalamic-pituitary-adrenal responses to stress. Science 1997;277:1659–1662.
23.
Suchecki D, Rosenfeld P, Levine S: Maternal regulation of the hypothalamic-pituitary-adrenal axis in the infant rat: The roles of feeding and stroking. Brain Res Dev Brain Res 1993;75:185–192.
24.
Oliff HS, Marek P, Miyazaki B, Weber E: The neuroprotective efficacy of MK-801 in focal cerebral ischemia varies with rat strain and vendor. Brain Res 1996;731:208–212.
1998
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.